FR3103677B1 - Utilisation d’un composé de type 4-(3-éthoxy-4 hydroxyphényl) alkylcétone contre les bactéries du complexe Burkholderia cepacia - Google Patents

Utilisation d’un composé de type 4-(3-éthoxy-4 hydroxyphényl) alkylcétone contre les bactéries du complexe Burkholderia cepacia Download PDF

Info

Publication number
FR3103677B1
FR3103677B1 FR1913366A FR1913366A FR3103677B1 FR 3103677 B1 FR3103677 B1 FR 3103677B1 FR 1913366 A FR1913366 A FR 1913366A FR 1913366 A FR1913366 A FR 1913366A FR 3103677 B1 FR3103677 B1 FR 3103677B1
Authority
FR
France
Prior art keywords
against bacteria
burkholderia cepacia
hydroxyphenyl
ethoxy
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1913366A
Other languages
English (en)
Other versions
FR3103677A1 (fr
Inventor
Sylvie Cupferman
Florence Menard-Szczebara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1913366A priority Critical patent/FR3103677B1/fr
Application filed by LOreal SA filed Critical LOreal SA
Priority to US17/778,216 priority patent/US20230037103A1/en
Priority to KR1020227016846A priority patent/KR20220084160A/ko
Priority to BR112022010367A priority patent/BR112022010367A2/pt
Priority to PCT/EP2020/083516 priority patent/WO2021105288A1/fr
Priority to EP20811348.0A priority patent/EP4064843A1/fr
Priority to JP2022530964A priority patent/JP7457117B2/ja
Priority to CN202080081831.XA priority patent/CN114745959B/zh
Publication of FR3103677A1 publication Critical patent/FR3103677A1/fr
Application granted granted Critical
Publication of FR3103677B1 publication Critical patent/FR3103677B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/04—Saturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/185—Saturated compounds containing keto groups bound to acyclic carbon atoms containing —CHO groups
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N35/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical
    • A01N35/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical containing aliphatically bound aldehyde or keto groups, or thio analogues thereof; Derivatives thereof, e.g. acetals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P1/00—Disinfectants; Antimicrobial compounds or mixtures thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00—Treatment of water, waste water, or sewage
    • C02F1/50—Treatment of water, waste water, or sewage by addition or application of a germicide or by oligodynamic treatment
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2303/00—Specific treatment goals
    • C02F2303/04—Disinfection

Abstract

Titre : Utilisation d’un composé de type 4-(3-éthoxy-4 hydroxyphényl) alkylcétone contre les bactéries du complexe Burkholderia cepacia La présente invention concerne l’utilisation de composés de formule (I) dans le traitement de produits notamment de compositions aqueuses ou non, de préférence l’eau et les compositions aqueuses, contre les bactéries du complexe Burkholderia cepacia (Bcc), ainsi que leur mise en œuvre dans un procédé de traitement de composition aqueuse ou de l’eau vis-à-vis de de souches du complexe Bcc. Formule (I) dans laquelle : - R2 représente un atome d'hydrogène ou un radical méthyle ou éthyle ;- R3 représente un radical alkyle (saturé) linéaire en C1-C12, éventuellement substitué par un groupe hydroxyle ; ou bien un radical alcényle (insaturé C=C) linéaire en C2-C12, éventuellement substitué par un groupe hydroxyle
FR1913366A 2019-11-28 2019-11-28 Utilisation d’un composé de type 4-(3-éthoxy-4 hydroxyphényl) alkylcétone contre les bactéries du complexe Burkholderia cepacia Active FR3103677B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR1913366A FR3103677B1 (fr) 2019-11-28 2019-11-28 Utilisation d’un composé de type 4-(3-éthoxy-4 hydroxyphényl) alkylcétone contre les bactéries du complexe Burkholderia cepacia
KR1020227016846A KR20220084160A (ko) 2019-11-28 2020-11-26 버크홀데리아 세파시아 컴플렉스의 박테리아에 대한 4-(3-에톡시-4-히드록시페닐) 알킬 케톤 유형의 화합물의 용도
BR112022010367A BR112022010367A2 (pt) 2019-11-28 2020-11-26 Uso de pelo menos um composto, processos para tratar produtos e composição
PCT/EP2020/083516 WO2021105288A1 (fr) 2019-11-28 2020-11-26 Utilisation d'un composé de type 4-(3-éthoxy-4-hydroxyphényl) alkylcétone contre les bactéries du complexe burkholderia cepacia
US17/778,216 US20230037103A1 (en) 2019-11-28 2020-11-26 Use of a compound of 4-(3-ethoxy-4-hydroxyphenyl) alkyl ketone type against bacteria of the burkholderia cepacia complex
EP20811348.0A EP4064843A1 (fr) 2019-11-28 2020-11-26 Utilisation d'un composé de type 4-(3-éthoxy-4-hydroxyphényl) alkylcétone contre les bactéries du complexe burkholderia cepacia
JP2022530964A JP7457117B2 (ja) 2019-11-28 2020-11-26 セパシア菌群の細菌に対する４－（３－エトキシ－４－ヒドロキシフェニル）アルキルケトン型の化合物の使用
CN202080081831.XA CN114745959B (zh) 2019-11-28 2020-11-26 4-(3-乙氧基-4-羟基苯基)烷基酮型化合物对抗洋葱伯克霍尔德菌群细菌的用途

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1913366A FR3103677B1 (fr) 2019-11-28 2019-11-28 Utilisation d’un composé de type 4-(3-éthoxy-4 hydroxyphényl) alkylcétone contre les bactéries du complexe Burkholderia cepacia
FR1913366 2019-11-28

Publications (2)

Publication Number Publication Date
FR3103677A1 FR3103677A1 (fr) 2021-06-04
FR3103677B1 true FR3103677B1 (fr) 2022-05-27

Family

ID=70456833

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1913366A Active FR3103677B1 (fr) 2019-11-28 2019-11-28 Utilisation d’un composé de type 4-(3-éthoxy-4 hydroxyphényl) alkylcétone contre les bactéries du complexe Burkholderia cepacia

Country Status (8)

Country Link
US (1) US20230037103A1 (fr)
EP (1) EP4064843A1 (fr)
JP (1) JP7457117B2 (fr)
KR (1) KR20220084160A (fr)
CN (1) CN114745959B (fr)
BR (1) BR112022010367A2 (fr)
FR (1) FR3103677B1 (fr)
WO (1) WO2021105288A1 (fr)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2950884B1 (fr) 2009-10-01 2011-11-11 Oreal Utilisation de derives de vanilline comme conservateur, procede de conservation, composes et composition
FR2973229B1 (fr) * 2011-04-01 2013-03-29 Oreal Procede cosmetique de traitement des odeurs corporelles humaines utilisant un compose 4-(3-ethoxy-4-hydroxyphenyl)alkylcetone ou 2-ethoxy 4-hydroxyalkyl phenol
FR2973228B1 (fr) * 2011-04-01 2014-08-01 Oreal Composition cosmetique comprenant du 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one
FR2973227B1 (fr) 2011-04-01 2014-08-08 Oreal Composition cosmetique comprenant du 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one
FR3022773B1 (fr) * 2014-06-30 2016-07-29 Oreal Utilisation de 4-(3-ethoxy-4-hydroxyphenyl)alkylcetone en tant qu'agent apaisant de la peau
CN110099668A (zh) * 2016-12-22 2019-08-06 欧莱雅 包含4-(3-乙氧基-4-羟基苯基)-2-丁酮的防腐剂及其在化妆品组合物中的用途
JP7170676B2 (ja) 2017-06-30 2022-11-14 ロレアル ４－（３－エトキシ－４－ヒドロキシフェニル）ブタン－２－オンを含有する抗菌性混合物及びそれを含有する化粧用組成物
JP7220680B2 (ja) 2017-06-30 2023-02-10 ロレアル ４－（３－エトキシ－４－ヒドロキシフェニル）ブタン－２－オン及びジオールを含有する抗菌性混合物、並びにそれを含有する化粧用組成物
BR112019027713B1 (pt) 2017-06-30 2023-03-21 L'oreal Mistura antimicrobiana, composição e uso de uma mistura antimicrobiana
EP3473100A1 (fr) * 2017-10-18 2019-04-24 Bayer Aktiengesellschaft Combinaisons de composés actifs à propriétés insecticides/acaricides
FR3073397B1 (fr) * 2017-11-10 2020-05-15 L'oreal Melange antimicrobien contenant du 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one et un compose de thiazolinone, et composition cosmetique le contenant

Also Published As

Publication number Publication date
CN114745959B (zh) 2024-04-12
JP2023503633A (ja) 2023-01-31
FR3103677A1 (fr) 2021-06-04
EP4064843A1 (fr) 2022-10-05
CN114745959A (zh) 2022-07-12
JP7457117B2 (ja) 2024-03-27
WO2021105288A1 (fr) 2021-06-03
US20230037103A1 (en) 2023-02-02
BR112022010367A2 (pt) 2022-08-16
KR20220084160A (ko) 2022-06-21

Similar Documents

Publication Publication Date Title
MA45222A (fr) Nouveaux dérivés de pipéridinyle, procédé de préparation de ceux-ci et compositions pharmaceutiques les contenant
MA44721B1 (fr) Inhibiteurs de mcl1 macrocycliques pour le traitement du cancer
MA45223B1 (fr) Nouveaux dérivés de pipéridinyle subsitués par (hétéro)aryle, leur procédé de préparation et compositions pharmaceutiques les contenant
MA42231B1 (fr) Nouveaux dérivés d'hydroxyacide, leur procédé de préparation, et compositions pharmaceutiques les contenant
BR112012007257A2 (pt) Uso de pelo menos um composto, processo de conservação de uma composição, composto e composições cosmética e dermatológica
EA201071034A1 (ru) Новые макроциклические ингибиторы репликаций вируса гепатита с
UY28877A1 (es) Compuestos de metil-aril o heteroaril-amida sustituida y composiciones
UY28878A1 (es) Compuestos de aril-o heteroarilamida ortosustituidos y composiciones
MA34300B1 (fr) Composés azotés hétérocycliques convenant comme inhibiteurs de la pde10
TN2009000544A1 (fr) Derives de benzimidazole
FR2973229B1 (fr) Procede cosmetique de traitement des odeurs corporelles humaines utilisant un compose 4-(3-ethoxy-4-hydroxyphenyl)alkylcetone ou 2-ethoxy 4-hydroxyalkyl phenol
BRPI0708685B8 (pt) composto de 4-oxoquinolina, seu uso e método para produção dos mesmos
MA29926B1 (fr) Derives de pyrazine
CO2019003482A2 (es) Compuestos derivados de ciclobutano o azetidina 1,3 disustituidos como inhibidores de la prostaglandina d sintasa hematopoyética
FR3003129B1 (fr) Composition biocide et procede de traitement de l'eau ou de surfaces en contact d'eau
MA38385A1 (fr) Nouvelle composition pour la stéatose hépatique non alcoolique (nafld)
MA32929B1 (fr) Lactames en tant qu'inhibiteurs de bêta-sécrétase
MX2019013561A (es) Compuestos de pirrolopiridina-anilina para el tratamiento de trastornos dermicos.
PE20090739A1 (es) Derivados de fenilcondensados con actividad sobre el colageno
MA35886B1 (fr) Dérivés de benzylsulfanilamide utilisés comme inhibiteurs -2 mogat
AR074801A1 (es) Monocarbamas y composiciones farmaceuticas que los contienen
BR112018069712A2 (pt) composto ou um sal farmacologicamente aceitável do mesmo, composição farmacêutica, método para administração de uma quantidade eficaz de uma composição farmacêutica, e, inibidor de tnf-a.
RU2008112884A (ru) Агент для снижения инсулинорезистентности
MX2022012575A (es) Compuestos para usarse para tratar la enfermedad de huntington.
MA32290B1 (fr) Nouvelle classe de spiro pipéridines pour le traitement de maladies neurodégénératives

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20210604

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5